Owlet (OWLT) Cash from Investing Activities (2020 - 2026)
Owlet's (OWLT) quarterly Cash from Investing Activities came in at -$415000.0 in Q1 2026, down 277.27% year-on-year from $234102.6 in Q1 2025, and up 15.13% on a QoQ basis from -$489000.0 in Q4 2025.
Owlet (OWLT) Cash from Investing Activities (2020 - 2026) Analysis & Trends
Owlet (OWLT) has 7 years of Cash from Investing Activities data on file, last reported at -$415000.0 in Q1 2026.
- On a quarterly basis, Cash from Investing Activities fell 277.27% year-over-year to -$415000.0 in Q1 2026; TTM through Mar 2026 was -$1.2 million, a 49.64% decrease from a year earlier, with the FY2025 full-year figure at -$943000.0, down 23.92% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$415000.0, up from -$489000.0 in the prior quarter.
- Over the last five years, Cash from Investing Activities for OWLT reached as high as -$8000.0 in Q1 2023 and fell as low as -$700000.0 in Q1 2022.
- Historically, Cash from Investing Activities has averaged -$220176.5 across 5 years, with a median of -$160000.0 in 2022.
- Across the five-year window, Cash from Investing Activities soared 98.86% in 2023 and slumped 4563.64% in 2024, its largest moves.
- Year by year, Cash from Investing Activities stood at -$162000.0 in 2022, then jumped by 82.1% to -$29000.0 in 2023, then tumbled by 500.0% to -$174000.0 in 2024, then sank by 181.03% to -$489000.0 in 2025, then advanced by 15.13% to -$415000.0 in 2026.
- Per Business Quant data, the three most recent Cash from Investing Activities figures were -$415000.0 in Q1 2026, -$489000.0 in Q4 2025, and -$255000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.66 Bn | 175.36 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 128.55 Bn | 125.68 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 108.38 Bn | 99.16 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 68.11 Bn | 66.66 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 47.19 Bn | 43.52 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Dexcom | 28.54 Bn | 27.42 Bn | 750.30 Mn | -298.50 Mn |
| 7 | GE HealthCare Technologies | 28.37 Bn | 26.09 Bn | 1.98 Bn | -2.50 Bn |
| 8 | Smith & Nephew | 26.90 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 25.53 Bn | 22.40 Bn | 2.07 Bn | -475.32 Mn |
| 10 | Owlet | 145.58 Mn | 104.57 Mn | 12.24 Mn | -415,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -415,000.00 |
| Mar 31, 2026 | -415,000.00 |
| Dec 31, 2025 | -489,000.00 |
| Dec 31, 2025 | -489,000.00 |
| Sep 30, 2025 | -255,000.00 |
| Sep 30, 2025 | -255,000.00 |
| Jun 30, 2025 | -89,000.00 |
| Jun 30, 2025 | -89,000.00 |
| Mar 31, 2025 | -110,000.00 |
| Mar 31, 2025 | -110,000.00 |
| Dec 31, 2024 | -174,000.00 |
| Dec 31, 2024 | -174,000.00 |
| Sep 30, 2024 | -513,000.00 |
| Sep 30, 2024 | -513,000.00 |
| Jun 30, 2024 | -37,000.00 |
| Jun 30, 2024 | -37,000.00 |
| Mar 31, 2024 | -37,000.00 |
| Mar 31, 2024 | -37,000.00 |
| Dec 31, 2023 | -29,000.00 |
| Dec 31, 2023 | -29,000.00 |